03/29/2022
•2022Press Release
Urgent Care For Children Collaborates With Visby Medical To Provide New Gold Standard Diagnostic For Sexually Transmitted Infections
Pediatric urgent care provider among first in the US to adopt new point-of-care STI diagnostic device in adolescents and young adults
![Placeholder-1 Placeholder-1](http://visbywpstaging.visbyon-site.net/wp-content/uploads/elementor/thumbs/Placeholder-1-qhtaeiohdzzjtvqlh35qrktphg0a08da1s82il9pi0.webp)
About Urgent Care for Children
Urgent Care for Children is a physician-founded pediatric urgent care provider with 20 clinics across the Southeast. UC4C’s licensed, on-site pediatricians and pediatric nurse practitioners offer acute diagnostic and treatment care for children ages zero to 21 with non-life-threatening needs. The company proudly runs the nation’s first sensory-inclusive urgent care facilities. For more information, visit www.childrensurgent.com or visit us on Facebook and Instagram.About Visby Medical™
Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The Company’s proprietary technology development program culminated in the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. The Visby Medical technology is also helping to fight the global pandemic via the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. Visby Medical is accelerating the delivery of fast and accurate, palm-sized PCR diagnostics to the point of care, and eventually for use at home. For more information, visit www.visbymedical.com. Follow Visby Medical on LinkedIn; Facebook, and Twitter. Media Contacts: Urgent Care for Children Anna Peacock – Vice President, Marketing and Communications Urgent Care for Children apeacock@childrensurgent.com (205) 882-5031 Visby Medical, Inc. Doug Hochstedler – Vice President, Health Porter Novelli (on behalf of Visby Medical, Inc.) doug.hochstedler@porternovelli.com (317) 645-8665Read more articles & insights
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today that it will award biotechnology company Visby Medical of San Jose, California, up to $1.8 million to develop a portable polymerase chain reaction (PCR) test that can detect gonorrhea and assess its susceptibility to ciprofloxacin.
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women
Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of care (POC) test.
Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.
Visby Medical Expands Series E Round to Over $135 Million
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.